v3.25.2
Condensed Consolidated Income Statements (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue $ 2,301 $ 2,169 $ 4,370 $ 4,202
Cost of revenue 1,409 1,350 2,710 2,631
Gross profit 892 819 1,660 1,571
Selling, general and administrative expenses 503 485 963 959
Research and development expenses 58 58 114 117
Restructuring and asset impairment charges 26 23 47 33
Operating income 305 253 536 462
Interest expense (9) (11) (17) (25)
Other non-operating income, net 3 4 7 10
(Loss)/gain on sale of businesses 0 1 (10) (4)
Income before taxes 299 247 516 443
Income tax expense (75) (53) (125) (96)
Net income 224 194 391 347
Net loss attributable to non-controlling interests 2 0 4 0
Net income attributable to Xylem $ 226 $ 194 $ 395 $ 347
Earnings per share:        
Basic (usd per share) $ 0.93 $ 0.80 $ 1.62 $ 1.43
Diluted (usd per share) $ 0.93 $ 0.80 $ 1.62 $ 1.43
Weighted average number of shares:        
Basic (in shares) 243,397 242,572 243,251 242,213
Diluted (in shares) 243,859 243,538 243,820 243,279
Revenue from products        
Revenue $ 1,911 $ 1,802 $ 3,620 $ 3,492
Cost of revenue 1,129 1,079 2,170 2,100
Revenue from services        
Revenue 390 367 750 710
Cost of revenue $ 280 $ 271 $ 540 $ 531